Jordan vs Syria: Cause of death, by non-communicable diseases, ages 0-4, female
Jordan
32.9%
in 2021
Syria
33.7%
in 2021
Jordan rank
82nd
Syria rank
80th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Jordan
- Syria
How they compare
Syria currently reports 33.7% against 32.9% in Jordan, a difference of 0.8%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Syria ahead.
Jordan ranks 82nd and Syria ranks 80th of 185 countries.
Across the 3 decades both report, Jordan averaged higher in 1 and Syria in 2.
Head to head by decade
| Decade | Jordan | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.0% | 30.5% | 2.6% | Syria |
| 2010s | 32.2% | 31.1% | 1.1% | Jordan |
| 2020s | 32.9% | 33.9% | 0.9% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Jordan or Syria?
- Syria, at 33.7% against 32.9% in Jordan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Jordan and Syria?
- 0.8%, with Syria ahead.
- How many years of comparable data are there for Jordan and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Jordan and Syria rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Jordan ranks 82nd and Syria ranks 80th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.